This randomized controlled trial examined long-term quality-of-life outcomes in 400 Swedish and Finnish men with localized prostate cancer randomized to either radical prostatectomy or watchful waiting, with a median follow-up of 12.2 years. Self-assessed high quality of life was reported by 35% in the prostatectomy group, 34% in the watchful
